Identification of genes specifically expressed in the accumulated visceral adipose tissue of OLETF rats.

The Otsuka Long-Evans Tokushima fatty (OLETF) rat is an animal model of type 2 diabetes, characterized by abdominal obesity, insulin resistance, hypertension, and dyslipidemia. To elucidate the underlying molecular mechanism of obesity and its related complications, we used representational difference analysis and identified the genes more abundantly and specifically expressed in the visceral adipose tissue (VAT) of obese OLETF rats compared with the diabetes-resistant counterpart, that is, Long-Evans Tokushima Otsuka (LETO) rats. By Northern blot analysis, we confirmed the differential expression of 13 genes, including 3 novel genes. The upregulated expression of well-characterized lipid metabolic enzymes, such as lipoprotein lipase, phosphoenolpyruvate carboxykinase, and cholesterol esterase, were observed in VAT of OLETF rats. We demonstrated the differential expression of secreted proteins in VAT of OLETF rats, such as thrombospondin 1 and contrapsin-like protease inhibitor. In contrast to lipid enzymes, the secreted proteins revealed exclusive mRNA expression and they were not detected in VAT of LETO rats. Furthermore, the novel genes OL-16 and OL-64 were also expressed specifically in VAT of OLETF rats and were absent in that of LETO rats and other tissues, including subdermal and brown adipose tissues. The C-terminal partial amino acid sequence of OL-64 revealed that it showed approximately 40% homology with alpha(1)-antitrypsin and it seemed to be a new member of the serine proteinase inhibitor (SERPIN) gene family. VAT of OLEFT rats had a unique gene expression profile, and the accumulated VAT-specific known and novel secreted proteins may play a role(s) in the pathogenesis of obesity and its related complications.

[1]  M. Iruela-Arispe,et al.  Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats. , 1999, Circulation.

[2]  R. Silverstein,et al.  Angiogenesis and atherosclerosis. The mandate broadens. , 1999, Circulation.

[3]  H. Makino,et al.  Screening for genes up-regulated in 5/6 nephrectomized mouse kidney. , 1999, Kidney international.

[4]  B. Spiegelman,et al.  Adipose Expression of the Phosphoenolpyruvate Carboxykinase Promoter Requires Peroxisome Proliferator-activated Receptor γ and 9-cis-Retinoic Acid Receptor Binding to an Adipocyte-specific Enhancer in Vivo* , 1999, The Journal of Biological Chemistry.

[5]  V. Poli,et al.  The Transcription Factor CCAAT/Enhancer-binding Protein β Regulates Gluconeogenesis and Phosphoenolpyruvate Carboxykinase (GTP) Gene Transcription during Diabetes* , 1999, The Journal of Biological Chemistry.

[6]  Yoshiro Saito,et al.  Selenoprotein P in Human Plasma as an Extracellular Phospholipid Hydroperoxide Glutathione Peroxidase , 1999, The Journal of Biological Chemistry.

[7]  G A Colditz,et al.  Abdominal adiposity and coronary heart disease in women. , 1998, JAMA.

[8]  K. Umesono,et al.  Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. , 1998, The Journal of clinical investigation.

[9]  N. Hoffman,et al.  A Novel, Multifunctional c-Cbl Binding Protein in Insulin Receptor Signaling in 3T3-L1 Adipocytes , 1998, Molecular and Cellular Biology.

[10]  Y. Kanwar,et al.  Characterization of mammalian translocase of inner mitochondrial membrane (Tim44) isolated from diabetic newborn mouse kidney. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Olefsky,et al.  TNF-α-Induced Insulin Resistance In Vivo and Its Prevention by Troglitazone , 1997, Diabetes.

[12]  Y. Matsuzawa,et al.  Analysis of an expression profile of genes in the human adipose tissue. , 1997, Gene.

[13]  D. Batlle,et al.  Representational difference analysis of cDNA of genes expressed in embryonic kidney. , 1997, Kidney international.

[14]  G. Banting,et al.  TGN38 and its orthologues: roles in post-TGN vesicle formation and maintenance of TGN morphology. , 1997, Biochimica et biophysica acta.

[15]  U. Suter,et al.  Identification and characterization of a cDNA and the structural gene encoding the mouse epithelial membrane protein-1. , 1996, Genomics.

[16]  S. Yamashita,et al.  Enhanced expression of PAI–1 in visceral fat: Possible contributor to vascular disease in obeisty , 1996, Nature Medicine.

[17]  A. Mizuno,et al.  Poor Capacity for Proliferation of Pancreatic β-Cells in Otsuka-Long-Evans-Tokushima Fatty Rat: A Model of Spontaneous NIDDM , 1996, Diabetes.

[18]  S. Yamashita,et al.  Rapid enhancement of acyl-CoA synthetase, LPL, and GLUT-4 mRNAs in adipose tissue of VMH rats. , 1996, The American journal of physiology.

[19]  U. Suter,et al.  Epithelial Membrane Protein-1, Peripheral Myelin Protein 22, and Lens Membrane Protein 20 Define a Novel Gene Family * , 1995, The Journal of Biological Chemistry.

[20]  A. Mizuno,et al.  Which is the primary etiologic event in Otsuka Long-Evans Tokushima Fatty rats, a model of spontaneous non-insulin-dependent diabetes mellitus, insulin resistance, or impaired insulin secretion? , 1995, Metabolism: clinical and experimental.

[21]  R. Simsolo,et al.  The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. , 1995, The Journal of clinical investigation.

[22]  U. Suter,et al.  Progress in the molecular understanding of hereditary peripheral neuropathies reveals new insights into the biology of the peripheral nervous system , 1993, Trends in Neurosciences.

[23]  K. Kawano,et al.  Spontaneous Long-Term Hyperglycemic Rat With Diabetic Complications: Otsuka Long-Evans Tokushima Fatty (OLETF) Strain , 1992, Diabetes.

[24]  L. Sjöström,et al.  The morphology and metabolism of intraabdominal adipose tissue in men. , 1992, Metabolism: clinical and experimental.

[25]  G. Blobel,et al.  Nopp 140 shuttles on tracks between nucleolus and cytoplasm , 1992, Cell.

[26]  A Tremblay,et al.  Visceral Obesity in Men: Associations With Glucose Tolerance, Plasma Insulin, and Lipoprotein Levels , 1992, Diabetes.

[27]  Barbara J. Reaves,et al.  Identification, molecular characterization and immunolocalization of an isoform of the trans-Golgi-network (TGN)-specific integral membrane protein TGN38. , 1992, The Biochemical journal.

[28]  Zhou Wang,et al.  A gene expression screen. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Y. Misumi,et al.  Molecular cloning and characterization of rat contrapsin-like protease inhibitor and related proteins. , 1991, Journal of biochemistry.

[30]  L. Kedes,et al.  Structure, chromosome location, and expression of the human gamma-actin gene: differential evolution, location, and expression of the cytoskeletal beta- and gamma-actin genes , 1988, Molecular and cellular biology.

[31]  R. Burk,et al.  Orphan selenoproteins. , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.

[32]  M. Thun,et al.  The effect of age on the association between body-mass index and mortality. , 1998, The New England journal of medicine.

[33]  K. Uysal,et al.  Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. , 1997, Nature.

[34]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.

[35]  W. Kannel,et al.  Regional obesity and risk of cardiovascular disease; the Framingham Study. , 1991, Journal of clinical epidemiology.